id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-V-0402-0005,FDA,FDA-2006-V-0402,Lynne L. Rice,Other,VRA-Approval for Variance,2007-12-21T05:00:00Z,2007,12,,,2008-04-11T23:22:39Z,,0,0,0900006480460c6c
FDA-2006-V-0402-0003,FDA,FDA-2006-V-0402,FDA/DDM,Other,CR-Correction,2006-06-23T04:00:00Z,2006,6,,,2008-04-11T23:22:39Z,,0,0,0900006480460c69
FDA-2006-V-0402-0004,FDA,FDA-2006-V-0402,FDA/DDM,Other,CR-Correction,2006-06-23T04:00:00Z,2006,6,,,2008-04-11T23:22:39Z,,0,0,0900006480460c6a
FDA-2006-V-0402-0002,FDA,FDA-2006-V-0402,FDA/ DDM to Bart Rocket Theatre,Other,ACK-Acknowledgement Letter,2006-06-20T04:00:00Z,2006,6,,,2008-04-11T23:22:39Z,,0,0,0900006480460c68
FDA-2006-V-0402-0001,FDA,FDA-2006-V-0402,FDA/ DDM to Bart Rocket Theatre,Other,ACK-Acknowledgement Letter,2006-06-20T04:00:00Z,2006,6,,,2008-04-11T23:22:38Z,,0,0,0900006480460c4a